Suj is a director with Baker Tilly’s digital solutions practice. He is a seasoned professional with more than 25 years of international experience in delivering global enterprise wide solutions. Suj has successfully led more than 150 projects and implementations across the pharmaceutical, medical device, banking and insurance sectors, working in industry, software companies and consulting firms.
Recently, Suj has focused on the life sciences sector, specializing in building and providing comprehensive solutions in commercial compliance, including spend transparency, healthcare professional (HCP) contracting, fair market value (FMV)/key opinion leader (KOL) management, grants management and commercial contracting solutions.
- Provided solutions and services to 10 of the top 20 pharmaceutical and medical device manufacturers to optimize compliance operations related to HCP engagement/contracting, transparency and grants/funding management
- Implemented global, federal and state spend transparency solutions for approximately 80 companies, including current state assessment, future state architecture/solution, implementation, third party system integration, data migration, deployment and launch/rollout
- Designed and installed HCP engagement solutions for 10 pharmaceutical and medical device manufacturers with integrations to payment systems, vendor management systems, contract management systems and HCP portals. In many cases clients were under a confidentiality, integrity and availability (CIA) and/or a data process agreement (DPA)
- Built outsourcing service models and programs to transfer high cost and resource heavy compliance operation’s daily tasks and responsibilities to lower cost services. Performed services for more than 40 clients
- Conducted FMV assessments for HCPs in the U.S. and globally. Generated rate ranges by country, tier, specialty and provided defensible methodology
- Performed live monitoring services for more than 25 speaker programs for a mid-size pharmaceutical manufacturer
- Neil G. Shastri Foundation (911 Victim), board member
- A Kids Place, active contributor
- Important role data analytics plays in mitigating risk and managing compliance, pharmaceutical compliance congress, presenter
- Operational challenges and realities in spend management and reporting panel discussion, annual summit on disclosure, transparency and aggregate spend for drug, device and biotech companies, presenter
- Strategies for dispute resolution and dispute processes, pharmaceutical compliance congress, presenter
- Closing the Loop: proactively resolving open payment disputes and inquiries, white paper, author
- Successfully Implementing an aggregate spend solution, disclosure summit, presenter
- “Aggregate Spend Reporting and the Sunshine Act”, pharmaceutical/biotech accounting and reporting update conference, presenter
- “Spend Reporting Continuum”, industry white paper, author
- The Basics of the Sunshine Act and The Implications for your Business, webinar, presenter
- Addressing gaps in the spend reporting continuum, annual pharmaceutical compliance congress, presenter
- Practical approaches to implementing an aggregate spend program, annual pharmaceutical regulatory and compliance and best practices forum, presenter
- Compliance with aggregate spend requirements, managed markets services/data niche conference, presenter
- “The Top Five Corporate Compliance Challenges”, corporate compliance insights, co-author
- Implementing a Flexible Aggregate Spend Solution That Can Manage All Necessary Information and Evolve as State and Federal Laws Change, Physician Payments Disclosure and Aggregate Spend Conference, presenter
